Romain A Colas Selected Research

Romain A Colas Research Topics

Disease

45	Inflammation (Inflammations) 01/2022 - 01/2013
7	Infections 01/2020 - 01/2014
4	Sepsis (Septicemia) 01/2018 - 12/2016
3	Fibrosis (Cirrhosis) 01/2020 - 07/2015
3	Arthritis (Polyarthritis) 01/2020 - 01/2016
2	Meningeal Tuberculosis (Tuberculous Meningitis) 03/2023 - 01/2018
2	Peritonitis 01/2022 - 10/2014
2	Neuroinflammatory Diseases 01/2021 - 11/2018
2	Critical Illness (Critically Ill) 01/2021 - 01/2017
2	Endotoxemia 01/2021 - 01/2018
2	Atherosclerotic Plaque (Atheroma) 11/2020 - 09/2016
2	Obesity 11/2020 - 07/2015
2	Rheumatoid Arthritis 10/2020 - 01/2017
2	Tuberculosis (Tuberculoses) 01/2020 - 01/2014
2	Brain Infarction 11/2019 - 01/2018
2	Tendinopathy (Tendonitis) 01/2019 - 01/2017
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2017 - 11/2014
2	Edema (Dropsy) 01/2016 - 01/2016
2	Chronic Obstructive Pulmonary Disease (COPD) 12/2015 - 10/2015
2	Pneumonia (Pneumonitis) 09/2015 - 11/2014
1	HIV Infections (HIV Infection) 01/2022
1	Colitis-Associated Neoplasms 01/2022
1	Hemorrhage 01/2021
1	Wounds and Injuries (Trauma) 01/2021
1	Multiple Organ Failure (MODS) 01/2021
1	COVID-19 01/2021
1	Frontotemporal Dementia (Semantic Dementia) 01/2021
1	Hemorrhagic Shock 01/2021
1	Hypoxia (Hypoxemia) 11/2020
1	End Stage Liver Disease 01/2020
1	Hyperalgesia 01/2020
1	Peripheral Arterial Disease 01/2020
1	ST Elevation Myocardial Infarction 08/2019
1	Rupture 01/2019
1	Seizures (Absence Seizure) 11/2018
1	Epilepsy (Aura) 11/2018
1	Infarction (Infarctions) 01/2018
1	Liver Diseases (Liver Disease) 01/2018
1	Ischemia 11/2017

Drug/Important Bio-Agent (IBA)

32	LipidsIBA 01/2022 - 10/2014
7	resolvin D1IBA 01/2022 - 07/2015
6	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 03/2023 - 02/2013
5	lipoxin A4IBA 01/2022 - 07/2015
4	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2020 - 02/2013
4	AcidsIBA 01/2018 - 01/2013
4	LipoxinsIBA 01/2016 - 07/2015
3	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 08/2019 - 12/2015
3	EnzymesIBA 01/2019 - 01/2017
3	Leukotriene B4IBA 01/2017 - 09/2015
3	EicosanoidsIBA 01/2017 - 01/2016
3	7,14- dihydroxydocosa- 4,8,10,12,16,19- hexaenoic acidIBA 12/2016 - 11/2014
2	AlbuminsIBA 01/2020 - 01/2018
2	Dinoprostone (PGE2)FDA Link 01/2020 - 01/2017
2	Essential Fatty AcidsIBA 01/2020 - 01/2016
2	lipoxin B4IBA 11/2019 - 01/2017
2	5S,12R,18R- trihydroxy- 6Z,8E,10E,14Z,16E- eicosapentaenoic acidIBA 11/2019 - 01/2017
2	protectin D1IBA 11/2018 - 01/2017
2	CytokinesIBA 01/2017 - 10/2015
2	resolvin D2IBA 01/2017 - 07/2015
2	Biomarkers (Surrogate Marker)IBA 01/2017 - 01/2014
2	ProstaglandinsIBA 01/2017 - 09/2015
2	Carbon MonoxideIBA 12/2016 - 09/2015
2	SmokeIBA 12/2015 - 10/2015
2	AutacoidsIBA 10/2014 - 01/2013
1	salicylhydroxamic acid (SHAM)IBA 01/2022
1	ZymosanIBA 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 11/2020
1	chenodeoxycholate sulfate conjugate (CDCS)IBA 11/2020
1	Antirheumatic Agents (DMARD)IBA 10/2020
1	Inflammation MediatorsIBA 01/2020
1	Dihydrotachysterol (AT 10)IBA 01/2020
1	Apolipoproteins E (ApoE)IBA 01/2020
1	Interleukin-4 (Interleukin 4)IBA 01/2020
1	Thromboxane A2 (A2, Thromboxane)IBA 11/2019
1	STAT1 Transcription FactorIBA 11/2019
1	Interleukin-10 (Interleukin 10)IBA 11/2019
1	Interleukin-6 (Interleukin 6)IBA 11/2019
1	Troponin T (Troponin T1)IBA 08/2019
1	5'-palmitoyl cytarabine (PLAC)IBA 01/2019
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2019
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2019
1	docosapentaenoic acidIBA 11/2018
1	Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)IBA 01/2018
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2018
1	CationsIBA 01/2018
1	TRPV Cation ChannelsIBA 01/2018
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2018
1	ImmunosorbentsIBA 01/2018
1	20-hydroxy-5,8,11,14-eicosatetraenoic acidIBA 01/2018
1	LigandsIBA 01/2018
1	LipopolysaccharidesIBA 01/2018
1	Calcitonin Gene-Related PeptideIBA 01/2018
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2018
1	Neuropeptide Receptors (Neuropeptide Receptor)IBA 01/2018
1	CD59 AntigensIBA 11/2017

Therapy/Procedure

9	Therapeutics 01/2022 - 09/2015
1	Vagus Nerve Stimulation 01/2022
1	Resuscitation 01/2021
1	Aftercare (After-Treatment) 11/2018